Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
Abstract Background Osteoprotegerin (OPG) is a glycoprotein that plays an important regulatory role in the skeletal, vascular, and immune system. It has been shown that OPG predicts chronic kidney disease (CKD) in diabetic patients. We hypothesized that OPG could be a risk marker of CKD development...
Main Authors: | Stella Bernardi, Barbara Toffoli, Fleur Bossi, Riccardo Candido, Elisabetta Stenner, Renzo Carretta, Fabio Barbone, Bruno Fabris |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-017-0625-3 |
Similar Items
-
Serum osteoprotegerin as an early marker of chronic kidney disease in hypertensive patients
by: Khaled A Elhefnawy, et al.
Published: (2019-01-01) -
Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
by: Kamińska J, et al.
Published: (2021-06-01) -
Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective
by: Pandey A, et al.
Published: (2018-03-01) -
THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01) -
Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease
by: M.M. Nascimento, et al.
Published: (2014-11-01)